98D-29594-64223
2 vaccinations
3 coded responses
23 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2021-07-24
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Registered dependents
8H9-31932-52319
Child or adolescent in my care · Female · 2021-07-24
Timeline
-
2021-07-23
Dose 1 — Pfizer-BioNTech
-
2021-07-24
Registered in v-safe
-
2021-07-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, VomitingAdult check-in
- 2021-07-25
-
2021-07-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-07-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-08-01
- 2021-08-08
- 2021-08-13
-
2021-08-22
Dose 2 — Pfizer-BioNTech
- 2021-08-22
- 2021-08-23
- 2021-08-24
-
2021-08-25
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Fair · Site: Pain · Headache, Muscle or body achesFree text: Shortness of breathMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-27
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Fair · Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-28
- 2021-08-29
- 2021-09-06
-
2021-09-12
Survey response — day 21, dose 2MedDRA: Dyspnoea — Feeling: FairFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2021-09-19
- 2021-09-26
- 2021-10-04
- 2021-11-21
- 2022-02-20
- 2022-08-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-23 | Pfizer-BioNTech | No |
| 2 | 2021-08-22 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Systemic reaction (other): Runny nose
Release 9 — day 21, dose 2
Symptoms: Shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SRO | Dyspnoea | ✓ | · | ✓ |
| SRO | Rhinorrhoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release